Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-22

FDA Approved: LEVORPHANOL TARTRATE — Supplemental Application (SpecGx LLC)

View source ↗

Summary

FDA approved a supplemental application for Levorphanol Tartrate submitted by SpecGx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levorphanol Tartrate (Levorphanol Tartrate)

Snippet

SUPPL AP for LEVORPHANOL TARTRATE (LEVORPHANOL TARTRATE)